Chinook Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -5.45 | -100% |
| P/S |
|
278.26 | 33.44 | 732.23% |
|
|
| P/BV |
|
3.86 | 4.64 | -16.9% |
|
|
| P/FCF |
|
-24.35 | 42.53 | -157.25% |
|
|
| Ev/Ebitda |
|
-9.92 | -17.68 | -43.87% |
|
|
| Ev/S |
|
267.08 | 22.59 | 1082.07% |
|
|
| Ev/FCF |
|
-13.68 | 47.55 | -128.77% |
|
|
| E/P |
|
-0.0637 | 0.0182 | -450% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2691.8 | -14.2 | 18851.36% | -3107.08 | -13.37% |
| ROE |
|
-41.23 | 9.78 | -521.44% |
|
|
| ROA |
|
-32.45 | 0.33 | -9931.5% |
|
|
| ROIC |
|
-24.01 | 7.63 | -414.5% |
|
|
| ROS |
|
-3026.23 | -26.41 | 11356.99% |
|
|
| ROCE |
|
-41.88 | 14.55 | -387.86% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.24 | -3.87 | -93.81% | -0.3459 | -30.63% |
| Nеt Debt/Ebitda |
|
0.4629 | -4.24 | -110.91% |
|
|
| Debt/Ratio |
|
0.0686 | 0.1853 | -62.96% |
|
|
| Debt/Equity |
|
0.1022 | 1.61 | -93.64% |
|
|
| Debt/Net Income |
|
-0.2134 | 10.06 | -102.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-69.36 | 30.62 | -326.52% | ||
| Growth impulse Ebitda in 5 years |
|
882.99 | -17.42 | -5168.83% | ||
| Growth impulse Net Income in 5 years |
|
355.11 | -52.26 | -779.51% | ||
| Growth impulse FCF in 5 years |
|
940 | -31.68 | -3067.17% | ||
| Growth impulse EPS in 5 years |
|
175.45 | -61.82 | -383.81% |
IP Score
4.1/10
